Login
- Titel:
Nivolumab plus cabozantinib (N plus C) versus sunitinib (S) for advanced renal cell carcinoma (aRCC): Outcomes by baseline disease characteristics in the phase 3 CheckMate 9ER trial.
- Dokumenttyp:
- Meeting Abstract
- Autor(en):
- Apolo, Andrea B.; Powles, Thomas; Burotto, Mauricio; Bourlon, Maria Teresa; Hsieh, James J.; Basso, Umberto; Shah, Amishi Yogesh; Suarez, Cristina; Porta, Camillo; Barrios, Carlos H.; Gurney, Howard; Kessler, Elizabeth R.; Retz, Margitta; George, Saby; Escudier, Bernard; Zhang, Joshua; Simsek, Burcin; Scheffold, Christian; Motzer, Robert J.; Choueiri, Toni K.
- Zeitschriftentitel:
- J Clin Oncol
- Jahr:
- 2021
- Band / Volume:
- 39 Suppl S
- Heft / Issue:
- 15
- Volltext / DOI:
- doi:10.1200/JCO.2021.39.15_suppl.4553
- Print-ISSN:
- 0732-183X
- TUM Einrichtung:
- Urologische Klinik und Poliklinik
BibTeX